
See exactly how URA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for URA and 80,000+ other tickers.
The Global X Uranium ETF, identified by the symbol URA, aims to replicate the overall performance of the Solactive Global Uranium & Nuclear Components Total Return Index. This objective includes tracking both the price appreciation and income generated by the index's constituents, measured before any of the ETF's operational fees and expenses are deducted.

Global X Uranium ETF is rated Buy, driven by surging energy demand from AI and electrification trends. URA offers diversified exposure to uranium, with Cameco comprising over 20% and Sprott Physical Uranium Trust nearly 6%. Uranium's 92% capacity factor, low emissions, and scalability position it as a critical solution for future energy shortfalls.

Uranium funds just shed nearly a third of their value at the exact moment AI power demand is shattering records, and the reason that contradiction matters comes down to which of three very different ETFs an investor happens to own.

Oklo has recently achieved a crucial milestone in the development of small modular reactors for nuclear energy. The VanEck Uranium and Nuclear ETF holds about 4.4% of its assets in Oklo stock.

Washington just directed $17.5 billion toward the nuclear supply chain, yet the ETFs most investors hold to capture that trade are quietly delivering something else entirely.

I rate the Global X Uranium ETF (URA) a BUY after its 18.9% correction, as stronger long-term contract pricing is set to support producer earnings. URA's recovery is likely to be led by established producers like Cameco, where improved contract prices are already becoming visible in realized earnings. The fund offers diversified exposure across uranium producers and the nuclear value chain, but carries heightened risk due to concentration and company-specific factors.